small molecule

TRICOR (MICRONIZED)

FENOFIBRATE

Loss of exclusivityloss of exclusivity
CompanyAbbVie Inc.See this company's full patent-cliff portfolio

Drug detail

Brand nameTRICOR (MICRONIZED)
Active ingredientFENOFIBRATE
Strength134MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJune 1999
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TRICOR (MICRONIZED) patent cliff — loss of exclusivity — | CliffBio